IL6 and neoplasm: IL-6-Nab combined with HMA completely eradicated OCSCs, and this combination blocked IL-6/IL6-R/pSTAT3-mediated ALDH1A1 expression, providing a strategy for tumor recurrence after chemotherapy (173).